Epicardial Fat, Visceral Fat and Coronary Atherosclerosis

Sponsor
Ziv Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01344694
Collaborator
(none)
110
1
8
13.7

Study Details

Study Description

Brief Summary

Background: Visceral fat is increasingly associated with metabolic syndrome and with fatty liver, a condition carrying a high risk of cardiovascular disease. The independent role of epicardial fat deposition in cardiovascular risk remains unclear.

Condition or Disease Intervention/Treatment Phase
  • Other: patient with liver fat
  • Other: pts. with excess of visceral fat
  • Other: control

Detailed Description

Background: Visceral fat is increasingly associated with metabolic syndrome and with fatty liver, a condition carrying a high risk of cardiovascular disease. The independent role of epicardial fat deposition in cardiovascular risk remains unclear. Aim: Evaluate the link between epicardial fat, visceral fat, liver fat accumulation and cardiovascular diseases and carotis atherosclerosis in patients with the major cardiovascular risk factors and with or without metabolic syndrome.

Study Design

Study Type:
Observational
Anticipated Enrollment :
110 participants
Time Perspective:
Retrospective
Official Title:
Association Between Epicardial Fat, Visceral Fat Accumulation & Cardiovascular Atherosclerosis
Study Start Date :
Jul 1, 2011
Anticipated Primary Completion Date :
Feb 1, 2012
Anticipated Study Completion Date :
Mar 1, 2012

Arms and Interventions

Arm Intervention/Treatment
patient with liver fat

30 patients with liver fat

Other: patient with liver fat
30 patient with liver fat

excess of visceral fat

50 pts. with excess of visceral fat

Other: pts. with excess of visceral fat
pts. with excess of visceral fat

control

30 control subjects

Other: control
30 control subjects

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients referred to cardiac CT will be the source of recruitment.

    • patients with excess of visceral fat,

    • 30 patients with liver fat accumulation

    • 30 sex-age-matched individual (controls) will be enrolled. All patients will undergo a complete family history, personal clinical history, physical examination and blood sampling for biochemical analysis.

    • Informed consent will be obtained from each individual.

    Exclusion Criteria:
    • subjects with severe morbid obesity (body mass index [BMI] > 40),

    • recent history of acute illness,

    • clinical history of ischemic heart disease and cerebrovascular disease,

    • typical chest pain,

    • previous coronary artery disease,

    • conventional coronary angiography, percutaneous interventions, coronary by pass grafting, renal failure, cancer patients,

    • subjects who take drugs that induces hepatic steatosis ( corticosteroids, estrogens, methotrexate, amiodarone and others)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ziv MC Safed Israel 13100

    Sponsors and Collaborators

    • Ziv Hospital

    Investigators

    • Principal Investigator: Nimer Assy, md, Ziv MC

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01344694
    Other Study ID Numbers:
    • 0020-11
    First Posted:
    Apr 29, 2011
    Last Update Posted:
    May 16, 2011
    Last Verified:
    Apr 1, 2011

    Study Results

    No Results Posted as of May 16, 2011